Ashwagandha & Liver Injury: What Clinicians Need to Know with Dr Eric Viegas

episode

The Root Cause Medicine Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

“My Wife Is Not Bipolar” Nurse Testifies & All The Signs of Possible Hypomania Discussed in Court 48 min · 20 Sep 2026 · Rotten Mango

Richard Arnold: US Correspondent talks potential escalation from US in the Middle East 5 min · 20 Sep 2026 · The Mike Hosking Breakfast

ON-AIR 🟢 - The Big Dogs Big Announcement 50 min · 20 Sep 2026 · The Morning Rumble

Chris Luxon: Prime Minister talks National's supermarket policy, police targets and the public sector 12 min · 20 Sep 2026 · The Mike Hosking Breakfast

PL Review: Man Utd Struggle & Brighton Sensational 46 min · 20 Sep 2026 · Football Daily

NPR News: 09-20-2026 4PM EDT 4 min · 20 Sep 2026 · NPR News Now

Report any issue

Source

Recorded05 Feb 2026

Publisherfeeds.fame.so ↗

Handlerec:15752197

Show notes

In this Root Cause Medicine podcast episode, we explore emerging concerns around ashwagandha-associated drug-induced liver injury (DILI). While ashwagandha remains one of the most widely used adaptogens in integrative medicine, recent international case reports have highlighted rare but clinically meaningful hepatic adverse events. This episode equips clinicians with a mechanistic understanding of potential risk factors, extraction methods that may increase vulnerability, and practical strategies for patient screening, education, and monitoring—without dismissing the therapeutic value of this foundational herb.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in